DE3650625T2 - AraB-Promoter und Verfahren zur Herstellung von Polypeptiden einschliesslich Cecropinen mittels mikrobiologischer Verfahren - Google Patents

AraB-Promoter und Verfahren zur Herstellung von Polypeptiden einschliesslich Cecropinen mittels mikrobiologischer Verfahren

Info

Publication number
DE3650625T2
DE3650625T2 DE3650625T DE3650625T DE3650625T2 DE 3650625 T2 DE3650625 T2 DE 3650625T2 DE 3650625 T DE3650625 T DE 3650625T DE 3650625 T DE3650625 T DE 3650625T DE 3650625 T2 DE3650625 T2 DE 3650625T2
Authority
DE
Germany
Prior art keywords
cecropin
gene
fusion protein
genetic
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3650625T
Other languages
German (de)
English (en)
Other versions
DE3650625D1 (de
Inventor
Jiunu Lai
Jar-How Lee
Yun-Long Lin
Dan Ray
Gary Wilcox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xoma Royalty Corp
Original Assignee
Xoma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Corp filed Critical Xoma Corp
Application granted granted Critical
Publication of DE3650625D1 publication Critical patent/DE3650625D1/de
Publication of DE3650625T2 publication Critical patent/DE3650625T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P15/00—Preparation of compounds containing at least three condensed carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE3650625T 1985-01-28 1986-01-24 AraB-Promoter und Verfahren zur Herstellung von Polypeptiden einschliesslich Cecropinen mittels mikrobiologischer Verfahren Expired - Fee Related DE3650625T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69530985A 1985-01-28 1985-01-28
US79747285A 1985-11-13 1985-11-13

Publications (2)

Publication Number Publication Date
DE3650625D1 DE3650625D1 (de) 1997-06-26
DE3650625T2 true DE3650625T2 (de) 1997-10-02

Family

ID=27105550

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3650625T Expired - Fee Related DE3650625T2 (de) 1985-01-28 1986-01-24 AraB-Promoter und Verfahren zur Herstellung von Polypeptiden einschliesslich Cecropinen mittels mikrobiologischer Verfahren
DE3689598T Expired - Lifetime DE3689598T2 (de) 1985-01-28 1986-01-24 Arab-promoter und verfahren zur herstellung von polypeptiden einschliesslich cecropinen mittels mikrobiologischer verfahren.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE3689598T Expired - Lifetime DE3689598T2 (de) 1985-01-28 1986-01-24 Arab-promoter und verfahren zur herstellung von polypeptiden einschliesslich cecropinen mittels mikrobiologischer verfahren.

Country Status (8)

Country Link
EP (2) EP0460709B1 (enExample)
JP (2) JPH082308B2 (enExample)
KR (1) KR870700095A (enExample)
AT (2) ATE101203T1 (enExample)
DE (2) DE3650625T2 (enExample)
FI (1) FI94774C (enExample)
NO (1) NO175870C (enExample)
WO (1) WO1986004356A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028530A (en) * 1985-01-28 1991-07-02 Xoma Corporation AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques
US5166321A (en) * 1985-01-28 1992-11-24 International Genetic Engineering, Inc. Cecropin polypetides with activity against Gram-positive and Gram-negative bacteria
US5597945A (en) * 1986-07-25 1997-01-28 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Plants genetically enhanced for disease resistance
DE3751338T2 (de) * 1986-07-25 1995-11-23 Univ Louisiana State Verfahren zum verleihen bei pflanzen eines widerstands gegen krankheiten und pest sowie neue gene in pflanzen die hierfür kodieren.
DE3716957A1 (de) * 1987-05-20 1988-12-01 Boehringer Mannheim Gmbh Expressionsvektor zur regulierbaren expression von fremdgenen in prokaryonten
DE3854476T2 (de) * 1987-07-06 1996-04-04 Univ Louisiana State Inhibierung von eukaryotischen pathogenen und neoplasmen mit lytischen peptiden.
US5861478A (en) * 1987-07-06 1999-01-19 Helix Biomedix, Inc. Lytic peptides
CA1327311C (en) 1987-07-06 1994-03-01 Jesse M. Jaynes Therapeutic antimicrobial polypeptides, their use and methods for preparation
EP0326419A3 (en) * 1988-01-27 1991-09-25 THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF AGRICULTURE Vaccines for the protection of animals against hypodermosis
US5631007A (en) * 1990-03-12 1997-05-20 Ciba-Geigy Corporation Anti-pathogenically effective compositions comprising lytic peptides and hydrolytic enzymes
PH30997A (en) * 1990-03-12 1997-12-23 Ciba Geigy Antipathologenically effective compositions comprising lytic peptides and hydrolytic enzymes.
IL114697A0 (en) * 1994-07-22 1995-11-27 Demeter Biotech Ltd Polypeptides comprising ubiquitin-lytic peptide fusion protein products deriving therefrom their preparation and use
US5589364A (en) * 1994-07-29 1996-12-31 Magainin Pharmaceuticals Inc. Recombinant production of biologically active peptides and proteins
GB9610967D0 (en) 1996-05-24 1996-07-31 Cambridge Antibody Tech Specific binding members,materials and methods
US6030807A (en) * 1996-09-10 2000-02-29 The Rockefeller University Highly regulable promoter for heterologous gene expression
AU2001242432B2 (en) 2000-02-24 2007-11-08 Eidgenossische Technische Hochschule Zurich Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis
EP1824980B1 (en) 2004-12-07 2010-04-28 Lonza Ag Rhamnose promoter expression system
EP2934532B1 (en) 2012-12-20 2019-10-23 Purdue Research Foundation Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
CA3019835A1 (en) 2016-04-08 2017-10-12 Purdue Research Foundation Methods and compositions for car t cell therapy
US11649288B2 (en) 2017-02-07 2023-05-16 Seattle Children's Hospital Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents
US11850262B2 (en) 2017-02-28 2023-12-26 Purdue Research Foundation Compositions and methods for CAR T cell therapy
CN120154716A (zh) 2018-01-22 2025-06-17 恩多塞特公司 Car t细胞的使用方法
JP7774961B2 (ja) 2018-02-06 2025-11-25 シアトル チルドレンズ ホスピタル ディー／ビー／エイ シアトル チルドレンズ リサーチ インスティテュート フルオレセイン結合エーテルリン脂質（ｆｌ－ｐｌｅ）で標識された腫瘍に対して最適なｔ細胞機能を示すフルオレセイン特異的ｃａｒ
CA3091674A1 (en) 2018-02-23 2019-08-29 Endocyte, Inc. Sequencing method for car t cell therapy
CN112575047B (zh) * 2020-12-29 2024-06-21 中农颖泰林州生物科园有限公司 一种提高饲料用的抗菌肽天蚕素收率的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US4335104A (en) * 1978-08-16 1982-06-15 United Chemical Corporation Anhydrous multi-purpose moisturizing composition
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4355104A (en) 1980-06-17 1982-10-19 Kabigen Ab Bacteriolytic proteins
US4520016A (en) * 1980-06-17 1985-05-28 Kabigen Ab Bacteriolytic proteins
IL68561A (en) 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
WO1985001746A1 (en) 1983-10-11 1985-04-25 Beatrice Companies, Inc. The manufacture and expression of genes for thaumatin

Also Published As

Publication number Publication date
WO1986004356A1 (en) 1986-07-31
NO175870C (no) 1994-12-21
NO863806L (no) 1986-11-19
EP0460709A1 (en) 1991-12-11
EP0211047B1 (en) 1994-02-02
EP0211047A4 (en) 1989-04-24
DE3689598T2 (de) 1994-06-30
JPH0767684A (ja) 1995-03-14
FI94774C (fi) 1995-10-25
FI863891A0 (fi) 1986-09-26
JPS62501538A (ja) 1987-06-25
EP0460709B1 (en) 1997-05-21
JPH082308B2 (ja) 1996-01-17
DE3650625D1 (de) 1997-06-26
ATE101203T1 (de) 1994-02-15
NO175870B (enExample) 1994-09-12
EP0211047A1 (en) 1987-02-25
KR870700095A (ko) 1987-02-28
FI863891L (fi) 1986-09-26
ATE153377T1 (de) 1997-06-15
FI94774B (fi) 1995-07-14
DE3689598D1 (de) 1994-03-17
NO863806D0 (no) 1986-09-24
JPH0829112B2 (ja) 1996-03-27

Similar Documents

Publication Publication Date Title
DE3650625T2 (de) AraB-Promoter und Verfahren zur Herstellung von Polypeptiden einschliesslich Cecropinen mittels mikrobiologischer Verfahren
US5357044A (en) Cecropins fusion proteins
US5206154A (en) Method of producing cecropins by microbiological techniques
DE3587558T2 (de) Rekombinante DNS-Vektoren fähig zur Apoaequorinexpression, Apoaequorinpeptide und deren Herstellung und diese Vektoren enthaltende Mikroorganismen.
EP0099084B1 (de) Verfahren zur Herstellung von Interferon und Expressionsvektoren dafür
DE69233008T2 (de) Fusionierung von Peptiden und Proteinen mit Thioredoxin und thioredoxin-ähnlichen Molekülen
DE3650553T2 (de) Verfahren zur Herstellung biologisch aktiver Rinder- und Schweine-Wachstumshormone und Mischung mit biologisch aktivem Schweine-Wachstumshormon
DE3785864T2 (de) Verfahren zur Herstellung von menschlichem Epidermalwachstumsfaktor und dessen Analogen.
DE69228705T2 (de) Methode zur rückfaltung von igf-i in eine aktive konformation
DE3853748T2 (de) Polypeptide mit aktivität gegen gram-positive und gram-negative bakterien.
EP0500108B1 (de) Verbesserte Aktivierung von rekombinanten Proteinen
DE3382575T2 (de) Dna-sequenzen, rekombinante dna-molekuele und verfahren zur herstellung von schweinewachstumshormonaehnlichen polypeptiden.
DD210304A5 (de) Verfahren zur herstellung eines replikablen vektors
DD297188A5 (de) Gm-csf und il-3 umfassende fusionsproteine
EP0764172A1 (de) Synthetische peptidanaloge des lungenoberflächenproteins sp-c
DE69224269T2 (de) Biosynthetisches Verfahren zur Herstellung von Protein
DE60224930T2 (de) Expressionsvektoren die signalpeptide aus bakteriophagen kodieren
DE3320339A1 (de) Expressionsvektor, verfahren zu seiner herstellung und verwendung des expressionsvektors zur herstellung eines polypeptids
DE3687112T2 (de) Verfahren zur ausscheidung von genprodukten in das wachstumsmedium von gram-negativen bakterien.
DE69106498T2 (de) Stamm ral-4, nützlich zur herstellung kleiner proteine und peptide.
DE68915204T2 (de) Biosynthetisches Verfahren zur Herstellung von chemischen Verbindungen.
EP0136472A1 (de) Herstellung von Sekretin
DE3856101T2 (de) Den DEO-P1-P2 Promotor enthaltende Expressionsplasmide und diese Plasmide enthaltende bakterielle Wirte
DE69929590T2 (de) Vektoren zur kontrollierter expression von rekombinanten genen in prokaryontischen zellen
DE69930118T2 (de) Verfahren zur herstellung von proteinen in transformierten hefezellen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee